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One of the most striking results of the human (and mammalian)
genomes is the low number of protein-coding genes. To-date, the
main molecular mechanism to increase the number of diﬀerent
protein isoforms and functions is alternative splicing. However, a
less-known way to increase the number of protein functions is the
existence of multifunctional, multitask, or ‘‘moonlighting’’,
proteins. By and large, moonlighting proteins are experimentally
disclosed by serendipity. Proteomics is becoming one of the very
active areas of biomedical research, which permits researchers to
identify previously unseen connections among proteins and path-
ways. In principle, protein–protein interaction (PPI) databases
should contain information on moonlighting proteins and could
provide suggestions to further analysis in order to prove the
multifunctionality. As far as we know, nobody has veriﬁed
whether PPI databases actually disclose moonlighting proteins.
In the present work we check whether well-established moon-
lighting proteins present in PPI databases connect with their
known partners and, therefore, a careful inspection of these
databases could help to suggest their diﬀerent functions. The
results of our research suggest that PPI databases could be a
valuable tool to suggest multifunctionality.
Moonlighting proteins alternative functions are mostly related
to cellular localization, cell type, oligomeric state and the
cellular concentration of ligands, substrates, cofactors and
products.1–5 In any case, moonlighting will complicate the
analysis and interpretation of protein networks of interactions,
functional genomics, metabolomics, knock-out and iRNA
phenotypes, genetic analysis of diseases, drug-target identiﬁcation,
toxicology and so on. Although some ﬁndings suggest involve-
ment of a protein in extra functions, i.e., ﬁnding them in
diﬀerent cellular locations; in amounts exceeding those
required for its catalytic known function, usually moonlighting
proteins are experimentally disclosed by serendipity; therefore
any alternative method to identify these proteins would be
very valuable. In a previous work, the possibility of identifying
moonlighting proteins by bioinformatics was explored by our
group.6 In the present work, we check whether the analysis of
protein interacting partners of well-established moonlighting
proteins can be reliable enough to disclose multifunctionality.
Fig. 1 Scheme of the method used in this work.
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Table 1 Demonstrated moonlighting proteins and their reported interacting partners found in APID. The ﬁrst column shows the protein
analyzed; the second column, the known additional function (or functions in some cases). The third column shows those interacting partners
contained in APID database, which agree with the reported extra-function according to their GO descriptors (fourth column)
Protein
Known moonlighting
functions
Database interacting
partners GO related functions
GO enrichment
P-value
Aconitase mtDNA maintenance ATP-dependent DNA
helicase MER3
GO:0017111: nucleoside-triphosphatase
activity
0.00461
GO:0030554: adenyl nucleotide binding 0.00648
GO:0001883: purine nucleoside binding 0.00664
GO:0001882: nucleoside binding 0.00685
GO:0008135: translation factor activity,
nucleic acid binding
0.00017
Aldolase Vacuolar H+-ATPase assembly V-type proton ATPase
subunit E 1
GO:0008553: hydrogen-exporting
ATPase activity
0.00361
GO:0042623: ATPase activity, coupled 0.00615
GO:0051117: ATPase binding 0.00677
GO:0046961: proton-transporting
ATPase activity, rotational
0.00857
GO:0016887: ATPase activity 0.00857
Enolase Bind to cytoskeletal structures Actin GO:0034621: cellular macromolecular
complex organization
7.54  105
GO:0032506: cytokinetic process 0.0053
GO:0007109: cytokinesis, completion of
separation
0.0021
Microtubule-associated
protein 4
GO:0007017: microtubule-based process 0.00286
GO:0051488: activation of anaphase-
promoting complex
0.00314
GO:0000920: cytokinetic cell separation 0.00418
Glyceraldehyde-
3-phosphate
dehydrogenase
Microtubule bundling Tubulin polymerization-
promoting protein
GO:0051015: actin ﬁlament binding 0.0071
GO:0001948: beta-catenin binding 0.00594
GO:0008017: microtubule binding 0.00251
Phosphate group transfer Phosphoglycerate
kinase 1
GO:0017111: nucleoside-triphosphatase
activity
0.00222
GO:0016462: pyrophosphatase activity 0.00316
GO:0016772: transferase activity,
transferring phosphorus-containing
groups
0.00104
Binds to RNA, RNA polymerase Heterogeneous nuclear
ribonucleoprotein Q
GO:0003727: single-stranded RNA
binding
0.00788
GO:0008266: poly(U) RNA binding 0.00094
GO:0003723: RNA binding 5.11  1013
Decrease blood insulin levels Growth factor receptor-
bound protein 2
GO:0043567: regulation of insulin-like
growth factor receptor signaling
pathway
0.00593
Nuclear tRNA export Ataxin-1 GO:0050658: RNA transport 0.001658
GO:0050657: nucleic acid transport 0.001658
GO:0051236: establishment of RNA
localization
0.001658
Signiﬁcant role in apoptosis TNF receptor-associated
factor 1
GO:0042981: regulation of apoptosis 4.03  106
GO:0006915: apoptosis 1.93  105
GO:0043065: positive regulation of
apoptosis
0.00053
GO:0006917: induction of apoptosis 0.00199
Vesicular transport Protein kinase C iota type GO:0016192: vesicle-mediated transport 0.00168
Glycogen
synthase kinase
3 Beta
Establishment and maintenance of
neuronal polarity
Synphilin-1 GO:0048667: cell morphogenesis
involved in neuron diﬀerentiation
1.25  106
GO:0048812: neuron projection
morphogenesis
1.59  106
GO:0048699: generation of neurons 5.73  106
GO:0030182: neuron diﬀerentiation 3.53  105
GO:0010975: regulation of neuron
projection development
0.00013
GO:0045664: regulation of neuron
diﬀerentiation
0.00032
GO:0051402: neuron apoptosis 0.0007
Pyruvate kinase Regulates transcriptional responses of
the thyroid hormone-binding protein
Nuclear hormone
receptor family
member nhr-111
GO:0005497: androgen binding 0.00619
GO:0008266: poly(U) RNA binding 0.0093
GO:0045744: negative regulation of
G-protein coupled receptor protein
signaling pathway
0.00053
GO:0043433: negative regulation of
transcription factor activity
0.00464
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Not only interacting partners of a protein could suggest its
function (‘‘guilty-by-association’’) but also the existence of
putative additional functions. It is known that function is closely
linked to interaction. In any case, it has to be kept in mind that
the current set of demonstrated moonlighting proteins is small
and the space of interacting proteins is quite incomplete.
Some authors have pointed out that there is a relationship
between protein conformational ﬂuctuations and promiscuous
functions in proteins. This promiscuity is possible thanks to
the structural properties of the structurally disordered regions7
that can facilitate the evolution of these proteins to achieve
extra functions.8 In solution, proteins exist in a range of
conformations,9 and structurally disordered regions can alter
their secondary-structure propensities as well as conforma-
tional ﬂexibility in response to diﬀerent environments or to the
interacting partners.10 Depending on these factors, this produces
a selection of certain conformations or even a population shift
that would be responsible for this functional promiscuity.
Recently, it has been stated that protein disorder could be
related to moonlighting in order to act as a hub.11 In fact, it
has been suggested that disordered regions are involved in the
moonlighting process in several neurological diseases.11
Fig. 1 shows a scheme of the procedure followed in our
analysis. Speciﬁcally, a number of moonlighting protein examples,
which are present in the protein–protein interacting (PPI)
databases, have been taken from the literature.2,4,12,13 All the
proteins of these references which have one or more partners
in the APID database have been analyzed. The protein
partners for these moonlighting proteins have been checked
in the APID PPI database14 at http://bioinfow.dep.usal.es/
apid/index.htm, which comprises most of the proteomics data
reported elsewhere (MINT, DIP, BioGRID, IntAct, HPRD
and BIND). To be functional, proteins need to bind their
partners; expressing function in the cell entails a network of
binding events. Function is based on events taking place
following binding, however, the binding may or may not
specify function.15 Some partners function descriptors are
closely linked to a speciﬁc function, while others function
descriptors are insuﬃciently linked to deﬁne a speciﬁc function.
To deal with this, a Gene Ontology enrichment analysis was
conducted. We have considered that the proteomics data
disclose a second function for the moonlighting protein if
the PPI database identiﬁes a Molecular Function or, in some
cases, a Biological Process according to the Gene Ontology
annotation,16 which is in agreement with the expected additional
function. Gene Ontology screening (www.geneontology.org)
can be performed directly from the APID database. Then a
Gene Ontology enrichment analysis was performed. For each
moonlighting protein detected in APID, we collected the GO
terms from its interacting partners and computed GO term
enrichment using GOStat R package.17 This function will
compute hypergeometric p-values for overrepresentation of each
GO term in the speciﬁed category among the GO annotations for
the interesting genes. We selected as a true moonlighting function
indicator, those GO terms with a p-value lower than 0.05. These
values are depicted in the last column of Table 1.
Table 1 shows the interacting partners for a number of
moonlighting proteins. In ESIw can be found an extension of
Table 1 for other well known moonlighting proteins, mainly
ribosomal. As can be seen in these tables, it becomes evident
that PPI databases disclose most of the moonlighting activities.
Therefore, PPI databases could be a valuable tool to suggest
multifunctionality. It deserves to be mentioned that, with the
exception of G3PDH, none of the set of moonlighting proteins
can be considered putative sticky proteins (considering sticky
as being those with >50 partners).18
APID database has been built from several interactomics
databases. In order to compare the achievement of identifying
a moonlighting protein—according to the procedure described
above—of these diﬀerent databases, we have selected as true
positives those proteins which achieve a high Connectivity and
Clustering Coeﬃcient with the query protein. All of the true
positives were counted for all of the cases analysed for each PPI
database and were divided by the total number of each analysed
case (i.e. collect all the proteins that interact with the analysed
proteins in each PPI). Table 2 shows the accuracy results.
Table 1 (continued )
Protein
Known moonlighting
functions
Database interacting
partners GO related functions
GO enrichment
P-value
Alpha-crystallin A Heat-shock protein Heat shock protein beta-1 GO:0043066 = negative regulation of
apoptosis
3.91  106
GO:0010941 = regulation of cell death 1.05  105
GO:0006915 = apoptosis 3.85  105
GO:0012501 = programmed cell death 4.01  105
GO:0051082: unfolded protein binding 0.0023
GO:0043027: caspase inhibitor activity 0.0077
Alpha-crystallin B Heat-shock protein Heat shock protein beta-1 GO:0051082: unfolded protein binding 0.0011
Heat shock protein beta-8 GO:0060561 = apoptosis involved in
morphogenesis
3.07  106
GO:0006916 = anti-apoptosis 0.00015
GO:0043066 = negative regulation of
apoptosis
0.000717
Table 2 Percentage of identiﬁcation of known moonlighting proteins
for the diﬀerent PPI databases contained in APID
PPI database Accuracy
MINT 0.6
DIP 0.833
BioGRID 0.75
IntAct 0.756
HPRD 0.714
BIND 0.65
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It is generally considered that experimental data from
proteomics contain many false positives, estimated to be up
to about 20%.19–21 This may easily induce proteomics
researchers to consider most of the unexpected partners as
false positives. This may represent a drawback for identifying
true multifunctional proteins. For example, ribosomal proteins
are generally considered false positives in the yeast two-hybrid
method. However, this protein class is prone to moonlighting,13
and a number of them could be true positives. Another
example is Aconitase: using the PPI Curate Yeast High
Conﬁdence Network database (HC),22 a well-demonstrated
moonlighting protein with several interactors such as Aconitase
(YLR304C) has been deleted in the curing process. Therefore,
searching for putative moonlighting proteins should be
performed on less curated databases such as DIP, MINT, APID.
Obviously, the number of partners of the moonlighting
proteins found in all of the PPI database can be high. The
proteins in Table 1 present from 6 to 20 partners (human
Glyceraldehyde 3 phosphate dehydrogenase is an exception
with 83 partners). Therefore, although PPI databases can
disclose multifunctional proteins (which is the objective of
our communication) to pick out the true partners that lead to
identify extra-functionality, this will not be, for the moment,
an easy task. For the moment, moonlighting true positives
would be found experimentally, and likely by serendipity.
Increasing the number of protein functions without
augmenting the number of genes can be achieved by several
main mechanisms: alternative splicing,23 moonlighting.2–4
Contrary to splicing, moonlighting can be used by micro-
organisms. For example, the classic example of a minimal cell,
Mollicutes (Mycoplasmas), seems to make extensive use of
moonlighting.24,25 As stated by Jeﬀery,26 current moonlighting
proteins ‘‘appear to be only the tip of the iceberg’’.
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